Solid lipid nanoparticles for the delivery of anti-microbial oligonucleotides

Ana Gonzalez-Paredes (Lead Author), Leopoldo Sitia, Angels Ruyra, Christopher Morris, Grant N. Wheeler, Michael McArthur, Paolo Gasco

Research output: Contribution to journalArticlepeer-review

42 Citations (Scopus)
38 Downloads (Pure)


Novel alternatives to antibiotics are urgently needed for the successful treatment of antimicrobial resistant (AMR) infections. Experimental antibacterial oligonucleotide therapeutics, such as transcription factor decoys (TFD), are a promising approach to circumvent AMR. However, the therapeutic potential of TFD is contingent upon the development of carriers that afford efficient DNA protection against nucleases and delivery of DNA to the target infection site. As a carrier for TFD, here we present three prototypes of anionic solid lipid nanoparticles that were coated with either the cationic bolaamphiphile 12-bistetrahydroacridinium or with protamine. Both compounds switched particles zeta potential to positive values, showing efficient complexation with TFD and demonstrable protection from deoxyribonuclease. The effective delivery of TFD into bacteria was confirmed by confocal microscopy while SLN-bacteria interactions were studied by flow cytometry. Antibacterial efficacy was confirmed using a model TFD targeting the Fur iron uptake pathway in E.coli under microaerobic conditions. Biocompatibility of TFDSLN was assessed using in vitro epithelial cell and in vivo Xenopus laevis embryo models. Taken together these results indicate that TFD-SLN complex can offer preferential accumulation of TFD in bacteria and represent a promising class of carriers for this experimental approach to tackling the worldwide AMR crisis.
Original languageEnglish
Pages (from-to)166-177
Number of pages12
JournalEuropean Journal of Pharmaceutics and Biopharmaceutics
Early online date20 Nov 2018
Publication statusPublished - Jan 2019

Cite this